👁️👁️ All eyes on the Market today

Plus three stocks that are soaring 🦅                                                                                                                                                                                                                                                                                                                                                                                                                 March 13, 2023 | [Read Online]( Good day, 360 – Here are our top 3 trade ideas today – these setups look primed! Be the best prepared trader on the Street! CALT - Up over 28% after phase 3 success UNCY - Continues to soar after $130 million investment TENX - Up over 30% in pre-market after receiving $6 price target from Roth MKM *A message from Biotech Stock Market News 🔥 Hot Stock of the Day 🔥 The market is buzzing about the potential of this [tiny $2 stock right now](. The stock just surged over 50% in a single day with the highest volume – ever! They have recently acquired a 40% interest in a premier clinical diagnostics and reference laboratory which has completed over 600,000 tests since inception. This transaction is expected to be accretive to earnings through a profit sharing agreement. The stock has made some [serious moves in the last few months](, and it will be exciting to see where it goes next… You can see that Yahoo Finance is showing several bullish indicators that are flashing green lights right now ✅ Learn more about this innovative company by [visiting this page now](. But don’t wait too long… an [opportunity at these levels]( might be gone before you know it! *Sponsored by Lifewater Media, see disclosures below. CALT - Up over 28% after phase 3 success Calliditas Therapeutics was gapping over 28% higher in the pre-market after its drug Nefecon® met its primary endpoint in its phase 3 trial. Nefecon demonstrated a highly statistically significant benefit over a placebo in patients with primary IgA nephropathy (IgAN) (the deterioration of kidney function). $21.24 has been acting as support so far in the pre-market and should be an important pivot level this morning. Above it, targets to the upside are $21.96 and then the pre-market high of $22.64. A break above that put $23, $23.50 and then $24 into play. Below $21.24, there is potential support at $21, $20 and $19, with gaps to fill at $17.94 and $16.83 below that. UNCY - Continues to soar after $130 million investment Kidney disease company, Unicycive Therapeutics (UNCY), is up over 400% in 5 days after announcing a private placement of up to $130 million in gross proceeds. $30 million would be upfront to finance the launch of Renazorb with up to an additional $100 million tied to satisfaction of milestones. At yesterday’s close, the stock still only had a market cap of $31.09 million according to Finviz, not including the placement. UNCY also received price targets of $6 from Maxim, $8 from H.C Wainwright and $5 from EF Hutton last week representing more potential upside from current levels. $2.87 is the high from last week and would be the first major target for bulls. Above it targets to the upside are $3, $3.50, $4, $4.50 and gap to fill at $5.85. Below $2.87, there is potential support at $2.50, $2.40 and $2.20. Below that targets are at $2, $1.80 and $1.40 to the downside. TENX - Up over 30% in pre-market after receiving $6 price target from Roth MKM Tenax Therapeutics (TENX) is up over 30% this morning after the Roth MKM upgrade. It should be noted that the company raised $15.6 million last month by offering shares at $1.80 and warrants at $2.25. $0.75 was resistance in the after-hours and should be an important pivot point moving forward. Above it, the first major target for bulls would be the pre-market high at $0.82. Above that targets to the upside would be $1, $1.50 and then $1.60 above that. Below $0.75 there is potential support at $0.67-$0.68 area, with $0.65, $0.55 and $0.5 targets below that. Economic Calendar (EST) - Monday March 13 (tradingeconomics.com/calendar) Upcoming (EST) - Tuesday March 14 (tradingeconomics.com/calendar) To Your Success! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions *PAID ADVERTISEMENT. RagingBull has been paid fifteen thousand dollars via ach bank transfer by Lifewater Media for advertising Avalon GloboCare from a period beginning on March thirteenth, 2023 through March fourteenth of the same year. RagingBull has been previously paid ten thousand dollars via ach bank transfer by Lifewater Media for advertising Avalon GloboCare from a period beginning on February thirteenth, 2023 through February fourteenth of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull, do not hold a position in Avalon GloboCare. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Avalon GloboCare, increased trading volume, and possibly an increased share price of the Avalon GloboCare securities, which may or may not be temporary and decrease once the marketing arrangement has ended. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at . TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](